PrimeRFP SCOUT · Federal Contract Recompete Brief

HT942523F0014Verogen reagents — Verogen, Inc

The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. PoP ended Nov 30, 2022 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Army Med Res Acq Activity

Awarding office

Verogen, Inc

Recipient

Nov 30, 2022

PoP end

$311K

Obligated

$311K

Potential

334516

NAICS

6640

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Verogen, Inc — $90

Contract facts

NONE

Contract numberHT942523F0014

Also listed asHT9425-23-F-0014

Also listed asW81XWH19A0002-HT942523F0014

AgencyArmy Med Res Acq Activity

Awarding officeArmy Med Res Acq Activity

Awarding agencyDepartment of Defense (DOD)

Funding agencyDepartment of Defense (DOD)

IncumbentVerogen, Inc

CAGE803G9

UEIN2ASZNFB5EV5

NAICS334516

No full NAICS 334516 intel page yet. Browse NAICS intelligence

PSC6640

Parent IDIQ / IDVW81XWH19A0002

Place of performanceSAN DIEGO CA

Pricing typeFirm Fixed Price

Extent competedNot Competed Under SAP

PoP startNov 3, 2022

PoP end (current)Nov 30, 2022

Obligated$311K

Current value$311K

Potential value$311K

VEROGEN REAGENTS is a federal NONE award for Army Med Res Acq Activity held by Verogen, Inc. Estimated value $311K ($311K obligated). Current period of performance ends Nov 30, 2022. Last award drew 1 bidder. Place of performance: SAN DIEGO CA.

Recompete timing

Public

● Past PoP end (1360 days ago)

Current PoP ended Nov 30, 2022 (1360 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract HT942523F0014?

HT942523F0014 (Verogen reagents) is a Army Med Res Acq Activity award with a potential value of $311K, currently held by Verogen, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is HT9425-23-F-0014?

HT9425-23-F-0014 is the dashed form of PIID HT942523F0014 (Verogen reagents), held by Verogen, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded HT942523F0014?

Army Med Res Acq Activity awarded HT942523F0014 to Verogen, Inc (potential $311K).

Who is the incumbent on HT942523F0014?

Verogen, Inc is the incumbent. The current period of performance ends Nov 30, 2022.

When does Verogen, Inc’s HT942523F0014 come up for recompete?

SCOUT tracks a period-of-performance end of Nov 30, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Nov 2, 2022 · refreshed monthly